Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank75
3Y CAGR+54.3%
5Y CAGR+65.7%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+54.3%/yr
vs +31.1%/yr prior
5Y CAGR
+65.7%/yr
Recent deceleration
Acceleration
+23.2pp
Accelerating
Percentile
P75
Within normal range
vs 5Y Ago
12.5x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $9.89M | -18.8% |
| 2024 | $12.17M | -8.7% |
| 2023 | $13.33M | +395.5% |
| 2022 | $2.69M | +1199.5% |
| 2021 | $207000.00 | -73.9% |
| 2020 | $792000.00 | +103.3% |
| 2019 | $-24.05M | -2743.0% |
| 2018 | $910000.00 | +3037.9% |
| 2017 | $29000.00 | - |